rs141209982
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_016123.4(IRAK4):c.529A>G(p.Thr177Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000537 in 1,610,808 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016123.4 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 67Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IRAK4 | NM_016123.4 | c.529A>G | p.Thr177Ala | missense_variant | Exon 5 of 12 | ENST00000613694.5 | NP_057207.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IRAK4 | ENST00000613694.5 | c.529A>G | p.Thr177Ala | missense_variant | Exon 5 of 12 | 1 | NM_016123.4 | ENSP00000479889.3 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000347 AC: 87AN: 251044 AF XY: 0.000346 show subpopulations
GnomAD4 exome AF: 0.000550 AC: 802AN: 1458538Hom.: 1 Cov.: 30 AF XY: 0.000551 AC XY: 400AN XY: 725442 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000414 AC: 63AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74458 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Immunodeficiency 67 Uncertain:2
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 177 of the IRAK4 protein (p.Thr177Ala). This variant is present in population databases (rs141209982, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with IRAK4-related conditions. ClinVar contains an entry for this variant (Variation ID: 574442). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IRAK4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.529A>G (p.T177A) alteration is located in exon 5 (coding exon 4) of the IRAK4 gene. This alteration results from a A to G substitution at nucleotide position 529, causing the threonine (T) at amino acid position 177 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at